Radiation treatment in age-related macular degeneration

Age-Related Macular Degeneration

Volumn , Issue , 2002, Pages 225-238

  Flaxel, Christina J ^a   Finger, Paul ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b New York AMDRT Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67749129764     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (75)

1. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640–1642.
2. American Academy of Ophthalmology. Age-Related Macular Degeneration, Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology, 1998.
3. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, Nickerson RJ, Pool J, Colton TL, Ganley JP, Loewenstein JI, Dawber TR. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 1980;24(Suppl):335–610.
4. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber TR. The Framingham eye study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham heart study. Am J Epidemiol 1977;106:33–41.
5. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982;100:571-573.
6. Vinding T. Age related macular degeneration, macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol 1989;67:609-616.
7. Macular Photocoagulation Study Group. Argon laser photocoagulation for AMD: results of a randomized clinical trial. Arch Ophthalmol 1982;100:912-918.
8. Macular Photocoagulation Study Group. Juxtafoveal CNVM. Arch Ophthalmol 1990; 108:1442.
9. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in AMD: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991; 109:1242-1257.
10. Macular Photocoagulation Study Group. Recurrent CNV after argon laser treatment for neovascular maculopathy. Arch Ophthalmol 1986;104:503-512.
11. Macular Photocoagulation Study Group. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 1996; 114:400-412.
12. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in AMD: results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-1231.
13. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal CNV secondary to AMD: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994;112:480-488.
14. Freund KB, Yanuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786-791.
15. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefe’s Arch Clin Exp Ophthalmol 1994;232:707-716.
16. Rezai KA, Kohen L, Wiedermann P, Heimann K. Iris pigment epithelium transplantation. Graefe’s Arch Clin Exp Ophthalmol 1997;235:558-562.
17. Thomas MA, Grand MG, Williams DF, Lowe MA. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992;99:952-968.
18. Scheider A, Gundisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration; results of a prospective study. Graefe’s Arch Clin Exp Ophthalmol 1999;237:10-15.
19. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation. II. A surgical approach for age-related macular degeneration? Graefe’s Arch Clin Exp Ophthalmol 1993;231:635-641.
20. Ninomiya Y, Lewis JM, Hasegawa T, Tana Y. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. Am J Ophthalmol 1996; 122:613-621.
21. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counterrotation of the globe in patients with age-related macular degeneration. Graefe’s Arch Clin Exp Ophthalmol 1999;37:313-325.
22. Lewis H, Kaiser PK, Lewis S, Estafanous M. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: A prospective study. Am J Ophthalmol 1999;128:135-146.
23. Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ, Gragoudas ES. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 1996;114:978-985.
24. Kliman GH, Puliafito CA, Stern D, Borirakchanyavat S, Gregory WA. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization. Lasers Surg Med 1994;15:2-10.
25. Lin SC, Lin CP, Feld JR, Duker JS, Puliafito CA. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. Curr Eye Res 1994;13:513-522.
26. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, Haimovici R, Gragoudas ES. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995;113:810-818.
27. Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, Crean DH. Photodynamic therapy for choroicapillaris using tin ethyl etiopurpurin (SnET2). Ophthalmic Surg Lasers 1997;28:409-417.
28. Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, Zografos L, Birn-gruber R, van den Bergh H, Strong A, Manjuris U, Fsadni M, Lane AM, Piguet B, Bressler NM Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefe’s Arch Clin Exp Ophthalmol 1998;236:365-374.
29. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials— TAP report. Arch Ophthalmol 1999;117:1329-1345.
30. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative degeneration and intravitreal triamcinolone: 18 month follow up. Aust NZ J Ophthalmol 1998;26:277-281.
31. D’Amato RJ, Loughan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994;91:4082-4085.
32. Pharmacological Therapy for Macular Degeneration Study Group. Interferon-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Arch Ophthalmol 1997;115:865-872.
33. Thomas MA, Ibanez HE. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization. Am J Ophthalmol 1993;115:563-568.
34. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: review of experimental treatments. Surv Ophthalmol 1998;32:134-146.
35. Verteporfin in Photodynamic Therapy [VIP] Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin: two year results of a randomized clinical trial including lesions with occult but not classic neovascularization—VIP Report #2. Am J Ophthalmol 2001; in press.
36. Brunner R, Widder RA, Walter P, Luke C, Godehardt E, Bartz-Schmidt KU, Heimann K, Borberg H. Influence of membrane differential filtration on the natural course of age-related macular degeneration, a randomized trial. Retina 2000;20:483-491.
37. Inhoffen W, Nussgens Z. Rheological studies on patients with posterior subretinal neovascularization in age-related macular degeneration. Graefe’s Arch Clin Exp Ophthalmol 1990;228:316-320.
38. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis and heat-shock proteins. Ophthalmic Surg Lasers 2000;313:359-373.
39. Finger PT and Augsberger JJ. Controversies, radiotherapy and the treatment of age-related macular degeneration. Arch Ophthalmol 1998;116:1507-1511.
40. Baker DG, Krochak RJ. The response of the microvascular system to radiation: a review. Cancer Invest 1989;37:287-294.
41. Krishnan L, Krishnan EC, Jewell WR. Immediate effect of irradiation on microvasculature. J Rad Oncol Biol Phys 1988;15:147-150.
42. Finger PT, Immonen I, Freire J, Brown G. Brachytherapy for macular degeneration associated with subretinal neovascularization. In: Alberti WE, Richard G, Sagerman RH, eds. Age-Related Macular Degeneration. Berlin: Springer-Verlag, 2001:167-172.
43. Chakravarthy U, Gardiner TA, Archer DB, Maguire CJF. A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds. Curr Eye Res 1989;8:337-348.
44. Archambeau JO, Mao XW, Yonemoto LT, Slater JD, Friedrichsen E, Teichman S, Preston W, Slater JM. What is the role of radiation in the treatment of subfoveal membranes? Review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussion. Int J Radiat Oncol Biol Phys 1998;40:1125-1136.
45. De Gowin RL, Lewis JL, Hoak JC, Mueller AL, Gibson DP. Radiosensitivity of human endothelial cells in culture. J Lab Clin Med 1974;84:42-48.
46. Hosoi Y, Yamamoto M, Ono T, Sakamoto K. Prostacyclin production in cultured endothelial cells is highly sensitive to low doses of ionizing radiation. Int J Radiat Biol 1993;63:631-638.
47. Johnson LK, Longenecker JP, Fajardo LF. Differential radiation response of cultured endothelial cells and smooth myocytes. Anal Quant Cytol 1982;4:188-198.
48. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997;42:215-232.
49. Sagerman RH, Chung CT, Alberti WE: Radiosensitivity of ocular and orbital structures. In: WE Alberti, RH Sagerman, eds. Radiotherapy of Intraocular and Orbital Tumors. Berlin: SpringerVerlag, 1993.
50. Langley RE, Bune EA, Quartuccio SG, Medeiras D, Braunhut SJ. Radiation induced apoptosis in microvascular endothelial cells. Br J Cancer 1997;75:666-672.
51. Finger PT, Chakravarthy Y. External beam radiation therapy is effective in the treatment of age-related macular degeneration. Arch Ophthalmol 1998;116:1507-1509.
52. Perez CA, Brady LW: Principles and Practice of Radiation Oncology, 2nd ed. Philadelphia: JB Lippincott, 1992.
53. Schilling H, Sauerwein W, Lommatzsch A, Friedrichs W, Brylak S, Bornfeld N, Wessing A. Long-term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol 1997;81:267-273.
54. Engenhart R, Wowra B, Debus J, Kimmig BN, Hover KH, Lorenz W, Wannenmacher M. The role of high-dose, single-fraction irradiation in small and large intracranial arteriovenous malformations. Int J Radiat Oncol Biol Phys 1994;30:521-529.
55. Scott TA, Augsburger JJ, Brady LW, Hernandez C, Woodleigh R. Low dose ocular irradiation for diffuse choroidal hemangiomas assoicated with bullous nonrhegmatogenous retinal detachment. Retina 1991;11:389-393.
56. Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ. Radiation retinopathy. Ophthalmology 1982;1494-1501.
57. Chan RC, Shukovsky LJ. Effects of irradiation on the eye. Radiology 1976;120:673-675.
58. Parsons JT, Fitzgerald CR, Hood CI, Ellingwood KE, Bova FJ, Million RR. The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys 1983;9:609-622.
59. Johnson LK, Longenecker JP, Fajardo LF. Differential radiation response of cultured endothelial cells and smooth myocytes. Anal Quant Cytol 1982;4:188-198.
60. Archer DB, Amoaku SMK, Gardinier TA. Radiation retinopathy, clinical, histological and ul-trastructural correlations. Eye 1991;5:239-251.
61. Plowman PN, Harnett AN. Radiotherapy in benign orbital disease. I: Complicated ocular angiomas. Br J Ophthalmol 1988;72:286-288.
62. Chakravarthy U, Houston RF, Acher DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993;77:265-273.
63. Study Protocol. Radiotherapy in the Management of Subfoveal Choroidal Neovascular Membranes of Age-Related Macular Degeneration. Belfast: 1995.
64. Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovascularization. Ophthalmology 1996;103:878-889.
65. Stalmans P, Leys A, Van Limbergen E. External beam radiation therapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: a review of 111 cases. Retina 1997;17:481-492.
66. Spaide RF, Guyer DR, McCormick B, Yanuzzi LA, Burke K, Mendelsohn M, Haas A, Slakter JS, Sorenson JA, Fisher YL, Abramson D. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998;105:24-30.
67. Donati G, Soubrane D, Quaranta M, Coscas G, Soubrane G. Radiotherapy for isolated occult subfoveal neovascularisation in age-related macular degeneration: a pilot study. Br J Ophthalmol 1999;83:646-651.
68. Mauget-Faysse M, Chiquet C, Milea D, Romestaing P, Gerard JP, Martin P, Koenig F. Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular dgeneration. Br J Ophthalmol 1999;83:923-928.
69. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127:170-177.
70. Bergink GJ, Deutman AF, van den Broek JFCM, van Daal WA, van der Maazen RW. Radiation therapy for age-related subfoveal choroidal neovascular membranes, a pilot study. Doc Ophthalmol 1995;90:67-74.
71. Bergink GJ, Hoyng CB, van der Maazen RWM. A randomized controlled trial on efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation. Graefe’s Arch Clin Exp Ophthalmol 1998;236:321-325.
72. Flaxel CJ, Friedrichsen EJ, Smith JO, Oeinck SC, Blacharski PA, Garcia CA, Chu HH. Proton beam irradiation of subfoveal choroidal neovascularization in age-related macular degeneration. Eye 2000;14:155-164.
73. The Radiation Therapy for Age-related Macular Degeneration (RAD) Study Group, A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Ophthalmology 1999;106:2239-2247.
74. Kobayashi H and Kobayashi K. Age-related macular degeneration: Long-term results of radiotherapy for subfoveal neovascular membranes. Am J Ophthalmol 2000;130:617-635.
75. Study Protocol. The Age-Related Macular Degeneration Radiation Trial (AMDRT), United States, 1999.